Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Spyre Therapeutics, Inc. | StockGist | StockGist

Companies
SYRE
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings SYRESCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Spyre Therapeutics, Inc.

Filed Jul 29, 2025

Accepted Jul 28, 2025, 8:00 PM ET

CIK 0001636282

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Spyre Therapeutics, Inc.

Person Type

IA

CUSIP: 00773J202

Amendment History

3 filings

SCHEDULE 13G
Original
Viewing
Jul 29, 20250000932471-25-001050
SCHEDULE 13G/A
Amendment 1
Feb 17, 20260001214659-26-002024
SCHEDULE 13G/A
Amendment 2
Latest
Mar 27, 20260000102909-26-002337

Recent Filings

Spyre Therapeutics, Inc.1 weeks ago

Spyre Therapeutics, Inc.1 months ago

Spyre Therapeutics, Inc.1 months ago

Spyre Therapeutics, Inc.1 months ago

Spyre Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice